Posts tagged “GSK”
GlaxoSmithKline takes home the honor as the top business on Fortune's annual "Change the World" list. Two other tech/biotech companies with a big North Carolina presence also are recognized: Novozymes and IBM.
Mayne Pharma's $50M GSK deal; UNC-CH opioid drug project; SAS targets heat, disease; RTI's $2M biofuels deal
In today's wrapup of tech and life science headlines from around the Triangle region: Mayne Pharma spends $50 million to acquire some GSK dermatology assets; UNC-CH researchers help develop an opioid drug candidate from scratch; SAS works with an Arizona county to fight heat and disease; and RTI International lands a $2M-plus biofuels contract.
One of Google's sister companies will team up with pharmaceuticals firm GlaxoSmithKline to form a joint venture that aims to develop tiny implants that can tap nerves and change their electronic signals as a way of treating chronic illnesses.
In today's Bulldog wrapup of life science and technology news: IBM's Watson to tackle cancer and GSK to speed up drug development; NASA fires a Mars booster (see video, photos); Mark Zuckerberg's new wall angers neighbors in Hawaii; and the FDA approves a pill to treat hepatitis C.
Tech Links: IBM Watson medical imaging; Google, AT&T vs. FCC; Lenovo smartphone supply chain; Tencent gaming buy; good GSK drug news
In today's Tech Links roundup of news impacting the Triangle: IBM forms a new Watson alliance for assessment of medical imaging - 2 reports; the FCC may budge on its cable box proposal after hearing opposition from AT&T and Google; Lenovo vows to revamp its supply chain to right smartphone business; Tencent, which owns a big part of Cary-based Epic Games, buys "Clash of Clans" creator; and GSK gets good news on a COPD combination therapy.
In today's wrapup of headlines on news impacting the Triangle tech community: Cisco's exec shuffle continues to generate headlines; Cisco CEO Chuck Robbins' video interview at Recode; GSK gets good news on an arthritis drug; and IBM's top IoT exec and Harriet Green on women in IT.
In today's "Tech links" wrapup of other media reports about news affecting the Triangle: AT&T reports blistering speeds at 5G lab; GSK loses bid to toss Avandia racketeering lawsuits; IBM wins a $300 million contract; and Lenovo adds new data center products as well as new partners.
Tech links: IBM's cognitive dress; Cisco cloud phone; Watson on Twilio; GSK lung drug success; Lenovo Moto Z
In today's roundup of Tech Links, taking you to important stories affecting tech in the Triangle: Check out the "cognitive dress" designed in part by IBM's Watson; see a YouTube video about the fashion project; read about Cisco's cloud phone; find out about new Watson services for developers at Twilio, GSK gets good news on a potential lung drug; and Lenovo trademarks Moto Z.
Tech links: 'Watson' at Moogest; free Cisco IoT training; AT&T connects cars; Red Hat bitcoin; Epic grants; China drug prices
In today's tech Links roundup of news affecting Triangle companies: IBM's Watson at Moogfest; Cisco plans free IoT training online; AT&T links cars and data; Red Hat offers more details on its bitoin initiative; Epic Games awards $75,000 in grants; and China slashes prices for GSK, AstraZeneca drugs.
Triangle headlines: GSK sells RTP buildings; Nortel bankruptcy ruling; Lenovo's $500M investment fund; Chinese firms like NC
In today's wrapup of Triangle area news: GSK sells its RTP buildings but plans to lease them back; a ruling may lead to Nortel bankruptcy settlement; Lenovo plans to invest $500 million in startups; and Chinese firms show a liking for North Carolina.
Pharmaceutical company GlaxoSmithKline says higher sales of vaccines and consumer healthcare products pushed up its earnings from core business by 19 percent in the first quarter. CEO Andrew Witty sees the results as an "encouraging start" for the year.
Drug giant GlaxoSmithKline made news official what had been rumored for months: CEO Andrew Witty is going to retire. Witty plans to step down a year from now. However, he says his decision is not linked to investor calls for breakup of the company.
Drug giant GlaxoSmithKline made news official what had been rumored for months: CEO Andrew Witty is going to retire. Witty plans to step down a year from now.
- Holden Beach 10-year-old uses popcorn business to buy Christmas gifts for other kids
- The colonel's secret recipe revealed? Not so fast, says KFC
- Fees grow faster than nest egg in NC employees' pension fund
- Raleigh nonprofit hopes 'pay what you want' pop-ups can help people get healthy meals
- Cree (again) recalls LED lamps that get too hot